BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38167828)

  • 1. Immune infiltration is associated with pan-cancer prognostic biomarker RING finger protein 187.
    Fan XT; Gao BF; Wang XF; Zhou K; Zhao Y; Yuan J
    J Mol Recognit; 2024 Mar; 37(2):e3071. PubMed ID: 38167828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic and immunological role of Ras-related protein Rap1b in pan-cancer.
    Cui G; Wang C; Lin Z; Feng X; Wei M; Miao Z; Sun Z; Wei F
    Bioengineered; 2021 Dec; 12(1):4828-4840. PubMed ID: 34346294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KIF18B is a Prognostic Biomarker and Correlates with Immune Infiltrates in Pan-Cancer.
    Qiu MJ; Wang QS; Li QT; Zhu LS; Li YN; Yang SL; Xiong ZF
    Front Mol Biosci; 2021; 8():559800. PubMed ID: 34109209
    [No Abstract]   [Full Text] [Related]  

  • 4. RecQ mediated genome instability 2 (
    Wei W; Ying X; Chen L; Sun Q; Lu X; Xia Y; Xu R; Zhu Z; Zhang D; Tang Q; Li L; Xie J; Yu H
    Aging (Albany NY); 2022 May; 14(9):4107-4136. PubMed ID: 35552266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pan-cancer analysis identifies RNF43 as a prognostic, therapeutic and immunological biomarker.
    Xu Y; Lin Z; Ji Y; Zhang C; Tang X; Li C; Liu T
    Eur J Med Res; 2023 Oct; 28(1):438. PubMed ID: 37848933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RING finger protein 187 as a novel potential biomarker for predicting the prognosis of ovarian carcinoma in 2 cancer centers.
    Chen J; Chen K; Zhou Z; Huang L; Cai Y; Tu H; Zhang X
    Curr Probl Cancer; 2020 Oct; 44(5):100555. PubMed ID: 32057463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive Pan-Cancer Analysis of KIF18A as a Marker for Prognosis and Immunity.
    Liu T; Yang K; Chen J; Qi L; Zhou X; Wang P
    Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of RNF187 induces cell EMT and apoptosis resistance in NSCLC.
    Fu Z; Yu W; Wang H; Chen X
    J Cell Physiol; 2019 Aug; 234(8):14161-14169. PubMed ID: 30624778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insights Into the Prognostic Value and Immunological Role of NAAA in Pan-Cancer.
    Huang D; Shen J; Zhai L; Chen H; Fei J; Zhu X; Zhou J
    Front Immunol; 2021; 12():812713. PubMed ID: 35069601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An essential role of RNF187 in Notch1 mediated metastasis of hepatocellular carcinoma.
    Zhang L; Chen J; Yong J; Qiao L; Xu L; Liu C
    J Exp Clin Cancer Res; 2019 Sep; 38(1):384. PubMed ID: 31477177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of P53 signaling in breast cancer by the E3 ubiquitin ligase RNF187.
    Li X; Niu Z; Sun C; Zhuo S; Yang H; Yang X; Liu Y; Yan C; Li Z; Cao Q; Ji G; Ding Y; Zhuang T; Zhu J
    Cell Death Dis; 2022 Feb; 13(2):149. PubMed ID: 35165289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pan-cancer evidence of prognosis, immune infiltration, and immunotherapy efficacy for annexin family using multi-omics data.
    Shen C; Zhang S; Zhang Z; Yang S; Zhang Y; Lin Y; Fu C; Li Z; Wu Z; Wang Z; Li Z; Guo J; Li P; Hu H
    Funct Integr Genomics; 2023 Jun; 23(3):211. PubMed ID: 37358720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic pan-cancer analysis identifies cuproptosis-related gene DLAT as an immunological and prognostic biomarker.
    Xu L; Wu P; Rong A; Li K; Xiao X; Zhang Y; Wu H
    Aging (Albany NY); 2023 May; 15(10):4269-4287. PubMed ID: 37199628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pan-cancer analysis reveals correlation between RAB3B expression and tumor heterogeneity, immune microenvironment, and prognosis in multiple cancers.
    Liu XS; Chen YL; Chen YX; Wu RM; Tan F; Wang YL; Liu ZY; Gao Y; Pei ZJ
    Sci Rep; 2024 Apr; 14(1):9881. PubMed ID: 38688977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycolytic regulatory enzyme PFKFB3 as a prognostic and tumor microenvironment biomarker in human cancers.
    Da Q; Huang L; Huang C; Chen Z; Jiang Z; Huang F; Shen T; Sun L; Yan Z; Ye X; Yi J; Huang Y; Da J; Ren M; Liu J; Wang T; Han Z; Ouyang K
    Aging (Albany NY); 2023 May; 15(10):4533-4559. PubMed ID: 37253634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Pan-Cancer Analysis Reveals CLEC5A as a Biomarker for Cancer Immunity and Prognosis.
    Chen R; Wu W; Chen SY; Liu ZZ; Wen ZP; Yu J; Zhang LB; Liu Z; Zhang J; Luo P; Zeng WJ; Cheng Q
    Front Immunol; 2022; 13():831542. PubMed ID: 35979347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA WAC-AS1 expression in human tumors correlates with immune infiltration and affects prognosis.
    Wang Y; Gong H; Cao Y
    Hereditas; 2023 May; 160(1):26. PubMed ID: 37248547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pan-Cancer Analysis of PDIA3: Identifying It as a Potential Biomarker for Tumor Prognosis and Immunotherapy.
    Zhang J; Wang K; Hainisayimu T; Li H
    Oxid Med Cell Longev; 2022; 2022():9614819. PubMed ID: 36046686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Significance and Immunological Role of FBXO5 in Human Cancers: A Systematic Pan-Cancer Analysis.
    Liu P; Wang X; Pan L; Han B; He Z
    Front Immunol; 2022; 13():901784. PubMed ID: 35720327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic Pan-Cancer Analysis Identifies TREM2 as an Immunological and Prognostic Biomarker.
    Cheng X; Wang X; Nie K; Cheng L; Zhang Z; Hu Y; Peng W
    Front Immunol; 2021; 12():646523. PubMed ID: 33679809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.